Khine Zaw Oo

Dr. Khine Zaw Oo

Medical Toxicology, Defence Services Medical Research Centre, Nay Pyi Taw, Myanmar
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2015 in Malaria Journal
Verified
Journal Article
Open access
PDF file
MAMatthew Adams
Matthew Adams
SJSudhaunshu N. Joshi
Sudhaunshu N. Joshi
GMGillian Mbambo
Gillian Mbambo
AMAmy Z. Mu
Amy Z. Mu
SRShay M. Roemmich
Shay M. Roemmich
CPChristopher V. Plowe
Christopher V. Plowe
Highly sensitive, scalable diagnostic methods are needed to guide malaria elimination interventions. While traditional microscopy and rapid diagnostic tests (RDTs) are suitable for the diagnosis of symptomatic malaria infection, more sensitive tests are needed to screen for low-density, asymptomatic infections that are targeted by interventions aiming to eliminate the entire reservoir of malaria infection in humans. A reverse transcription polymerase chain reaction (RT- PCR) was developed for multiplexed detection of the 18S ribosomal RNA gene and ribosomal RNA of Plasmodium falciparum and Plasmodium vivax. Simulated field samples stored for 14 days with sample preservation buffer were used to assess the analytical sensitivity and specificity. Additionally, 1750 field samples from Southeastern Myanmar were tested both by RDT and ultrasensitive RT-PCR. Limits of detection (LoD) were determined under simulated field conditions. When 0.3 mL blood samples were stored for 14 days at 28 °C and 80 % humidity, the LoD was less than 16 parasites/mL for P. falciparum and 19.7 copies/µL for P. vivax (using a plasmid surrogate), about 10,000-fold lower than RDTs. Of the 1739 samples successfully evaluated by both ultrasensitive RT-PCR and RDT, only two were RDT positive while 24 were positive for P. falciparum, 108 were positive for P. vivax, and 127 were positive for either P. vivax and/or P. falciparum using ultrasensitive RT-PCR. This ultrasensitive RT-PCR method is a robust, field-tested screening method that is vastly more sensitive than RDTs. Further optimization may result in a truly scalable tool suitable for widespread surveillance of low-level asymptomatic P. falciparum and P. vivax parasitaemia.
1

1 December 2018 in Data in Brief
Verified
Journal Article
Open access
KHKyaw Soe Htun
Kyaw Soe Htun
YFYang Fong
Yang Fong
AKAye Aye Kyaw
Aye Aye Kyaw
SASi Thu Aung
Si Thu Aung
KOKhine Zaw Oo
Khine Zaw Oo
THTin Maung Hlaing
Tin Maung Hlaing
This article contains microbiome data from the upper respiratory tract of patients living with HIV/TB, HIV and TB from Meiktila, a town in Myanmar where there is a high incidence of HIV and TB. Microbiomes were compared for HIV/TB infected and healthy adults from the same population. We collected nasopharyngeal and oropharyngeal swabs from a total of 33 participants (Healthy {5}, HIV/TB {8}, HIV {14}, and TB {6}). DNA was extracted from the swabs and subjected to custom single step 16s rRNA sequencing on an Illumina MiSeq platform. The sequencing data is available via http://www.ncbi.nlm.nih.gov/bioproject/ PRJNA432583.

20 December 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
KOKhine Zaw Oo
Khine Zaw Oo
ZHZaw Win Htun
Zaw Win Htun
NANay Myo Aung
Nay Myo Aung
KWKo Ko Win
Ko Ko Win
KLKyaw Zawl Lin
Kyaw Zawl Lin
KLKo Ko Lwin
Ko Ko Lwin
In December 2019, the COVID-19 disease started in Wuhan, China. The WHO declared a pandemic on 12 March 2020, and the disease started in Myanmar on 23 March 2020. In December 2020, different variants were brought worldwide, threatening global health. To counter those threats, Myanmar started the COVID-19 variant surveillance program in late 2020. Whole genome sequencing was done six times between January 2021 and March 2022. Among them, 83 samples with a PCR threshold cycle of less than 25 were chosen. Then, we used MiSeq FGx for sequencing and Illumina DRAGEN COVIDSeq pipeline, command line interface, GISAID, and MEGA version 7 for data analysis. In January 2021, no variant was detected. The second run, during the rise of cases in June 2021, showed Alpha, Delta, and Kappa variants. The third and the fourth runs in August and December showed only a Delta variant. Omicron and Delta variants were detected during the fifth run in January 2022. The sixth run in March 2022 showed only Omicron BA.2. Amino acid mutation at the receptor binding domain of Spike glycoprotein started since the second run coupling with high transmission, recurrence, and vaccine escape. We also found the mutation at the primer targets used in current RT-PCR platforms, but there was no mutation at the existing antiviral drug targets. The occurrence of multiple variants and mutations claimed vigilance at ports of entry and preparedness for effective control measures. Genomic surveillance with the observation of evolutionary data is required to predict imminent threats of the current disease and diagnose emerging infectious diseases.

4 July 2022
Verified
Book Chapter
Closed access
SKSann Lin Ko
Sann Lin Ko
TWThin Thin Win
Thin Thin Win
KOKhine Zaw Oo
Khine Zaw Oo
TWTun Tun Win
Tun Tun Win
AKAye Moe Moe Kyaw
Aye Moe Moe Kyaw
The cardiac muscle fibre over the segment of the coronary artery was known as “myocardial bridge”. The myocardial bridge was associated with coronary atherosclerosis and myocardial ischemia because of endothelial damage of coronary with myocardial bridge. The present study explored the ultrastructural changes of coronary arterial endothelium in human adult autopsy hearts with the myocardial bridge. The aim of the study is to compare the scanning electron microscopic features of the endothelium and calcium depositions between four segments of the coronary artery. The sample was collected from North Okkalarpa General and Teaching Hospital, Yangon. Forty-five adults autopsied hearts with myocardial bridge among the 243 cases had measured the length and thickness of the myocardial bridge. Then, four pieces of the coronary artery were taken in proximal, under, and distal segments of the coronary artery with a myocardial bridge and a segment from the coronary artery without a myocardial bridge in the same autopsy hearts to be used as control. The endothelial features and elements composition of each specimen was examined with a scanning electron microscope (Phenom Pro X) operated at 15 kV with energy dispersion X-ray spectrometry (EDS). In the present study, forty-five bridges (18.5%) were observed among the 243 hearts and there were located on the Left Anterior Descending Artery (LAD) (100% in all cases. The mean length of the myocardial bridge was 18.3 mm \(\pm\) 11.7 (range 1.5-59 mm). The mean thickness of the myocardial bridge was 2.8 mm \(\pm\) 1.5 (range 1-6.3 mm). Comparing endothelial cell gradings, the proximal segment was significantly different endothelial grading from the under-bridging segment, distal segment, and control segment. The under-bridging segment was significantly different from the distal segment. The control segment was not significantly different from both the under-bridging segment and the distal segment. Calcium deposition in the proximal segment was significantly different from the under-bridging segment, distal segment, and control segment. The under-bridging segment was a similar deposition of calcium in the distal segment and control segment. The distal segment was not significantly different from the control segment (P<0.05). The proximal segment was the most endothelial damage site due to haemodynamic changes affected by the myocardial bridge. The under-bridging segment was the least endothelial damage site which might be due to the atheroprotective effect of the myocardial bridge in the under segment.

11 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KOKhine Zaw Oo
Khine Zaw Oo
ZHZaw Win Htun
Zaw Win Htun
NANay Myo Aung
Nay Myo Aung
KWKo Ko Win
Ko Ko Win
SHSett Paing Htoo
Sett Paing Htoo
KLKo Ko Lwin
Ko Ko Lwin
Background In December 2019, the COVID-19 disease started in Wuhan, China. WHO declared a pandemic on March 12, 2020, and the disease started in Myanmar on March 23, 2020. December brought variants around the world, threatening the healthcare systems. To counter those threats, Myanmar started the COVID-19 variant surveillance program in late 2020. Methods Whole genome sequencing was done six times between January 2021 and March 2022. We chose 83 samples with a PCR threshold cycle of less than 25. Then, we used MiSeq FGx for sequencing and Illumina DRAGEN COVIDSeq pipeline, command line interface, GISAID, and MEGA version 7 for data analysis. Result and Discussion January 2021 results showed no variant. The second run during the rise of cases in June 2021 showed multiple variants like Alpha, Delta, and Kappa. There is only Delta in the third run at the height of mortality in August, and Delta alone continued until the fourth run in December. After the world reported the Omicron variant in November, Myanmar started a surveillance program. The fifth run in January 2022 showed both Omicron and Delta variants. The sixth run in March 2022 showed only Omicron BA.2. Amino acid mutation at receptor binding domain (RBD) of Spike glycoprotein started since the second run coupling with high transmission, recurrence, and vaccine escape. We also found the mutation at the primer targets used in current RT-PCR platforms. Conclusion The occurrence of multiple variants and mutations claimed vigilance at ports of entry and preparedness for effective control measures. Genomic surveillance with the observation of evolutionary data is required to predict imminent threats of the current disease and diagnose emerging infectious diseases.
1

15 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
NANay Myo Aung
Nay Myo Aung
KHKyaw Kaen Myo Htut
Kyaw Kaen Myo Htut
ZHZaw Min Htike
Zaw Min Htike
KKKyaw Khine
Kyaw Khine
WMWin Myat
Win Myat
ZLZaw Lwin
Zaw Lwin
Background: The global rise of Multidrug-Resistant (MDR) Escherichia coli (E. coli) represents a critical public health threat, severely compromising the treatment of infections. While Sequence Type 224 (ST224) is recognized as an emergent, high-risk lineage associated with extra-intestinal pathogenic E. coli (ExPEC) and MDR phenotypes globally, its specific genomic features and epidemiological footprint in Southeast Asia, particularly Myanmar, remain largely underexplored. Given Myanmar's vulnerability as an AMR hotspot, comprehensive genomic surveillance is critically leveraged. Method: A laboratory based cross sectional descriptive study conducted at Defense Services Medical Research Centre (DSMRC) during 20th January to 11th November 2025 and aimed to develop Oxford Nanopore Technologies (ONT) long-read sequencing, an early manifestation of this approach for bacterial genomic characterization in Myanmar. Five clinical MDR E. coli isolates (NMA_MM001) from (No.1) Defense Service General Hospital (DSGH) which were identified by Vitek2 analyzer were collected. Extracted DNA was sequenced on the MinION device at DSMRC. Bioinformatic analysis utilized the ONT EPI2ME platform for de novo assembly, followed by MLST, ResFinder, and PlasmidFinder analyses to characterize the isolate's resistome, mobilome, and virulence. Results: Out of five isolates, MDR E. coli (NMA_MM001) of ONT sequencing successfully generated a high-quality, near-closed assembly (N50: 4,911,841 bp, 5 contigs). MLST classified the isolate as ST224. This study confirmed a severe MDR phenotype, identifying blaDHA-1 (AmpC beta-lactamase), blaTEM-1, and two plasmid-mediated quinolone resistance genes (qepA4 and qnrB4). Crucially, the carbapenemase gene blaNDM-5 was identified, located on a highly mobile IncFII plasmid (pAMA1167-NDM-5). This constitutes the first report detailing the emergence of this NDM-5-producing ST224 lineage and its high genomic complexity in Myanmar. Conclusion: This study validates ONT long-read sequencing as an indispensable tool for resolving complex MDR genomes in resource-limited settings. The findings confirm the establishment of an MDR E. coli ST224 isolate in Myanmar carrying the critical blaNDM-5 carbapenemase gene on a highly mobile IncFII plasmid. This genomic information, identification of E. coli ST224, provides an urgent early warning of a highly resistant pathogen, mandating the immediate implementation of targeted infection control measures and regional One Health surveillance programs.